Safety and efficacy of tocilizumab in COVID-19: A systematic evaluation of adverse effects and therapeutic outcomes
Background: While COVID-19 has transitioned from a pandemic to an endemic state, the management of its persistent complications continues to present substantial clinical challenges. Tocilizumab, an interleukin-6 receptor antagonist endorsed by the World Health Organization (WHO) for severe COVID-19...
Gardado en:
| Principais autores: | , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Elsevier
2025-10-01
|
| Series: | Journal of Infection and Public Health |
| Assuntos: | |
| Acceso en liña: | http://www.sciencedirect.com/science/article/pii/S1876034125002229 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|